260 related articles for article (PubMed ID: 18543280)
81. Relation of histopathological features to prognosis of gallbladder cancer.
Hisatomi K; Haratake J; Horie A; Ohsato K
Am J Gastroenterol; 1990 May; 85(5):567-72. PubMed ID: 2337060
[TBL] [Abstract][Full Text] [Related]
82. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
83. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
Chen WT; Hung WC; Kang WY; Huang YC; Chai CY
Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
[TBL] [Abstract][Full Text] [Related]
84. Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer.
Montavon C; Gloss BS; Warton K; Barton CA; Statham AL; Scurry JP; Tabor B; Nguyen TV; Qu W; Samimi G; Hacker NF; Sutherland RL; Clark SJ; O'Brien PM
Gynecol Oncol; 2012 Mar; 124(3):582-8. PubMed ID: 22115852
[TBL] [Abstract][Full Text] [Related]
85. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
86. Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer.
Jain K; Mohapatra T; Das P; Misra MC; Gupta SD; Ghosh M; Kabra M; Bansal VK; Kumar S; Sreenivas V; Garg PK
Ann Surg; 2014 Dec; 260(6):1073-80. PubMed ID: 24827397
[TBL] [Abstract][Full Text] [Related]
87. [Histogenesis of gallbladder cancer with special reference to metaplastic changes and distribution of various mucins and CEA].
Inada A; Konishi F; Yamamichi N; Ito H
Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):894-906. PubMed ID: 2796960
[TBL] [Abstract][Full Text] [Related]
88. Endocrine cells and lysozyme immunoreactivity in the gallbladder.
Yamamoto M; Nakajo S; Tahara E
Arch Pathol Lab Med; 1986 Oct; 110(10):920-7. PubMed ID: 2429636
[TBL] [Abstract][Full Text] [Related]
89. High frequency of promoter methylation of the 14-3-3 sigma and CAGE-1 genes, but lack of hypermethylation of the caveolin-1 gene, in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.
Kunze E; Schlott T
Int J Mol Med; 2007 Oct; 20(4):557-63. PubMed ID: 17786288
[TBL] [Abstract][Full Text] [Related]
90. Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma.
Xie F; Xu X; Xu A; Liu C; Liang F; Xue M; Bai L
Hum Pathol; 2014 Mar; 45(3):513-21. PubMed ID: 24440094
[TBL] [Abstract][Full Text] [Related]
91. Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis.
Yanagisawa N; Yamashita K; Kuba T; Okayasu I
Anticancer Res; 2010 Nov; 30(11):4443-9. PubMed ID: 21115891
[TBL] [Abstract][Full Text] [Related]
92. Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer.
Singh D; Bharti A; Biswas D; Tewari M; Kar AG; Ansari MA; Singh S; Narayan G
J Gastrointest Cancer; 2022 Jun; 53(2):237-244. PubMed ID: 33417200
[TBL] [Abstract][Full Text] [Related]
93. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease.
Sharma P; Bhunia S; Poojary SS; Tekcham DS; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
Tumour Biol; 2016 Nov; 37(11):14687-14699. PubMed ID: 27623942
[TBL] [Abstract][Full Text] [Related]
94. p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.
Agrawal V; Goel A; Krishnani N; Pandey R; Agrawal S; Kapoor VK
J Postgrad Med; 2010; 56(4):262-6. PubMed ID: 20935395
[TBL] [Abstract][Full Text] [Related]
95. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W
Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088
[TBL] [Abstract][Full Text] [Related]
96. Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population.
Singh N; Kazim SN; Sultana R; Tiwari D; Borkotoky R; Kakati S; Nath Das N; Kumar Saikia A; Bose S
Free Radic Res; 2019 May; 53(5):473-485. PubMed ID: 31117842
[TBL] [Abstract][Full Text] [Related]
97. Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancer.
Baghel K; Kazmi HR; Chandra A; Raj S; Srivastava RN
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e120-e125. PubMed ID: 30740890
[TBL] [Abstract][Full Text] [Related]
98. Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features.
Lee YM; Lee JY; Kim MJ; Bae HI; Park JY; Kim SG; Kim DS
Cancer Sci; 2006 Nov; 97(11):1205-10. PubMed ID: 16965602
[TBL] [Abstract][Full Text] [Related]
99. [The relation of stone and carcinoma of the gallbladder based on the mucosal findings].
Yamagiwa H; Onishi N; Terada
Gan No Rinsho; 1990 Oct; 36(12):2131-6. PubMed ID: 2232182
[TBL] [Abstract][Full Text] [Related]
100. Reg IV expression and clinicopathologic features of gallbladder carcinoma.
Tamura H; Ohtsuka M; Washiro M; Kimura F; Shimizu H; Yoshidome H; Kato A; Seki N; Miyazaki M
Hum Pathol; 2009 Dec; 40(12):1686-92. PubMed ID: 19716164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
